Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: Findings from the REDUCE trial

A. Karim Kader, Jielin Sun, Brian H. Reck, Paul J. Newcombe, Seong Tae Kim, Fang Chi Hsu, Ralph B. D'Agostino, Sha Tao, Zheng Zhang, Aubrey R. Turner, Greg T. Platek, Colin F. Spraggs, John C. Whittaker, Brian R. Lane, William B. Isaacs, Deborah A. Meyers, Eugene R. Bleecker, Frank M. Torti, Jeffery M. Trent, John D. McConnellS. Lilly Zheng, Lynn D. Condreay, Roger S. Rittmaster, Jianfeng Xu

Research output: Contribution to journalArticlepeer-review

86 Scopus citations

Fingerprint

Dive into the research topics of 'Potential impact of adding genetic markers to clinical parameters in predicting prostate biopsy outcomes in men following an initial negative biopsy: Findings from the REDUCE trial'. Together they form a unique fingerprint.

Medicine & Life Sciences